
Cosmetics trends 2026 skin scalp and hair care
The cosmetic care paradigm is evolving towards longevity and preservation. Formulators need actives that respond to well-aging, scalp care and long-term hair health. Cobiosa presents at In-Cosmetics Global 2026 solutions based on fermented biotechnology and plant stem cells to address these trends with scientific rigour.


Definition

Add a Title

Add a Title

Add a Title
Related products
- 1. Trends in skin, scalp and hair care
2. Cobiosa actives for longevity and wellbeing
3. Applications and formulations for the formulator
Key trends in skin and hair care 2026
The cosmetic sector is undergoing a shift in focus: from one-off correction to sustained preservation. Concepts such as skinspan, hairspan and well-aging define a new consumer demand that formulators must integrate from ingredient selection. This direction demands actives with demonstrated efficacy on the biological mechanisms of ageing.
Skinspan and hairspan: preserve, don't correct
The skinspan concept translates the idea of extending the biological functionality of the skin over time into skin care. Analogously, hairspan applies this logic to hair and the scalp. The formulator must select actives capable of maintaining tissue homeostasis, hair density and structural integrity before signs of ageing become visible.
In-Cosmetics Global 2026 consolidated three strategic axes: skin longevity, preventive hair health and sustainable biotechnology. Brands are no longer talking about anti-ageing — they talk about skin longevity and healthy ageing. Actives combining clinical efficacy with biotechnological origin and verifiable technical storytelling are gaining market share in 2026 launches across all markets.
Skin longevity and well-aging: the industry's new language
Skin, scalp and hair care trends 2026
Contents
Cobiosa's biofermented actives for 2026
Cobiosa presents at In-Cosmetics Global 2026 three actives differentiated by their biotechnological origin and clinical data: Cyanage, Balanzza and Vineactyl. Each responds to a specific formulator need in the categories of skin longevity, scalp balance and hair care, backed by in vivo and in vitro studies.
Cyanage: postbiotic for skin longevity
Cyanage is a postbiotic active obtained by biofermentation, designed to act on the 12 hallmarks of aging. It acts on interconnected ageing mechanisms: chronic inflammation, cellular senescence, mitochondrial dysfunction and microbiome disruption. In 28-day clinical studies it shows wrinkle reduction and texture improvement.
Balanzza and Vineactyl: scalp and hair with data
Balanzza, derived from Quillaja saponaria stem cells, offers antifungal, keratolytic and follicle protection action. In studies: >99% reduction of Malassezia furfur, 54.29% reduction of Cutibacterium acnes and 26.2% reduction in dandruff index in 28 days. Vineactyl increases scalp hydration and breaking strength.

Formulations for longevity and hair wellbeing
The three Cobiosa actives cover the full spectrum of sector trends: from deep cutaneous anti-ageing to comprehensive scalp treatment and structural hair quality. Their biotechnological origin makes them compatible with natural and sustainable positioning, aligned with current market demand.
Cobiostem Alerce: extracellular vesicles
Cobiostem Alerce incorporates plant-derived extracellular vesicles, naturally enriched, with a concentration of 1.5 × 10¹¹ particles/ml confirmed by transmission electron microscopy (TEM). This active enhances next-generation cell communication, integrating into the trend for exosome-inspired ingredients in advanced formulations.
Practical applications for formulators
These actives can be integrated into anti-ageing serums, hair treatments, anti-dandruff products and next-generation scalp care formulations. The Cobiosa technical team can guide formulators on concentrations, synergies and most appropriate galenical formats. Contact the Cobiosa technical team to request formulations.
Definition
Skin longevity, well-aging and scalp care trends mark the direction of the cosmetic market towards 2026. Cobiosa offers biotechnological actives with clinical data to respond to these demands with rigour. Contact the Cobiosa technical team or download the complete monograph to integrate these solutions in your next formulations.




